These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25300812)

  • 1. Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study.
    Ferrari M; Romualdi E; Dentali F; Squizzato A; Marino F; Cosentino M; Ageno W
    Thromb Res; 2014 Dec; 134(6):1359-62. PubMed ID: 25300812
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients.
    Au A; Aziz Baba A; Goh AS; Wahid Fadilah SA; Teh A; Rosline H; Ankathil R
    Biomed Pharmacother; 2014 Apr; 68(3):343-9. PubMed ID: 24581936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases.
    Fischer S; Lakatos PL; ; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Szilvasi A; Tulassay Z; Osztovits J; Papp J; Demeter P; Schwab R; Tordai A; Andrikovics H
    Scand J Gastroenterol; 2007 Jun; 42(6):726-33. PubMed ID: 17505995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.
    Kopp TI; Andersen V; Tjonneland A; Vogel U
    Scand J Gastroenterol; 2015; 50(12):1469-81. PubMed ID: 26109419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polymorphism of ABCB1 and ABCG2 genes encoding drug transporters and their investigation by pyrosequencing].
    Dribnokhodova OP; Mironov KO; Dunaeva EA; Shipulin GA
    Eksp Klin Farmakol; 2012; 75(10):29-36. PubMed ID: 23240156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease.
    Cascorbi I; Flüh C; Remmler C; Haenisch S; Faltraco F; Grumbt M; Peters M; Brenn A; Thal DR; Warzok RW; Vogelgesang S
    Pharmacogenomics; 2013 Apr; 14(5):485-94. PubMed ID: 23556446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.
    Martino A; Campa D; Buda G; Sainz J; García-Sanz R; Jamroziak K; Reis RM; Weinhold N; Jurado M; Ríos R; Szemraj-Rogucka Z; Marques H; Szemraj J; Stein A; Kumar R; Orciuolo E; Gemignani F; Landi S; Goldschmidt H; Petrini M; Dumontet C; Canzian F; Rossi AM
    Leukemia; 2012 Jun; 26(6):1419-22. PubMed ID: 22182917
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma.
    Drain S; Flannely L; Drake MB; Kettle P; Orr N; Bjourson AJ; Catherwood MA; Alexander HD
    Leuk Res; 2011 Nov; 35(11):1457-63. PubMed ID: 21705081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the ABCG2 and ABCB1 drug transporter polymorphisms on the pharmacokinetics of bicalutamide in humans.
    Kim KA; Cha YJ; Lee HM; Joo HJ; Park JY
    Clin Chim Acta; 2015 Jan; 438():7-11. PubMed ID: 25124867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: evidence from in vitro and in vivo experiments.
    To KK; Hu M; Tomlinson B
    Pharmacogenomics; 2014 Jun; 15(8):1091-104. PubMed ID: 25084202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid.
    Choi HY; Bae KS; Cho SH; Ghim JL; Choe S; Jung JA; Jin SJ; Kim HS; Lim HS
    Pharmacogenet Genomics; 2015 Dec; 25(12):595-608. PubMed ID: 26367500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
    Bruhn O; Cascorbi I
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular response to imatinib & its correlation with mRNA expression levels of imatinib influx & efflux transporters in patients with chronic myeloid leukaemia in chronic phase.
    Malhotra H; Sharma P; Malhotra B; Bhargava S; Jasuja S; Kumar M
    Indian J Med Res; 2015 Aug; 142(2):175-82. PubMed ID: 26354214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia.
    Kim DH; Sriharsha L; Xu W; Kamel-Reid S; Liu X; Siminovitch K; Messner HA; Lipton JH
    Clin Cancer Res; 2009 Jul; 15(14):4750-8. PubMed ID: 19584153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid regulation of the ABCB1 and ABCG2 multidrug transporters.
    Hegedüs C; Telbisz Á; Hegedűs T; Sarkadi B; Özvegy-Laczka C
    Adv Cancer Res; 2015; 125():97-137. PubMed ID: 25640268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar.
    Tang SC; Nguyen LN; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Int J Cancer; 2014 Mar; 134(6):1484-94. PubMed ID: 24037730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients.
    Francis J; Dubashi B; Sundaram R; Pradhan SC; Chandrasekaran A
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1185-9. PubMed ID: 26546461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.